Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fluoxetine
Drug ID BADD_D00932
Description Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI).[A181673] It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.[L7721]
Indications and Usage Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664]
Marketing Status approved; vet_approved
ATC Code N06AB03
DrugBank ID DB00472
KEGG ID D00326
MeSH ID D005473
PubChem ID 3386
TTD Drug ID D0TR5X
NDC Product Code 0093-0807; 43063-839; 53002-2305; 61919-869; 62332-243; 71335-0924; 0615-8093; 0093-7198; 50090-3180; 50111-647; 50228-421; 59651-308; 68645-130; 0615-7625; 72241-009; 0904-5785; 0904-7195; 49884-468; 55111-150; 59651-324; 62332-242; 65862-306; 71209-041; 61919-885; 63304-632; 72241-008; 80426-044; 63187-233; 63629-8179; 70518-3752; 71335-0565; 80425-0313; 59651-309; 13668-443; 46708-273; 68645-131; 80426-045; 23155-028; 23155-030; 42291-398; 42571-388; 62332-024; 63187-089; 71335-1048; 0904-5784; 23155-029; 42291-396; 42571-389; 62332-022; 72162-1506; 72241-007; 16714-112; 16714-113; 42291-397; 42571-387; 43598-566; 46708-272; 50228-420; 58118-0645; 70518-1619; 71209-042; 13668-473; 50111-648; 55154-1341; 61919-100; 62332-023; 63629-2201; 71205-178; 71205-188; 71209-040; 42708-025; 46708-271; 53002-5016
UNII 01K63SUP8D
Synonyms Fluoxetine | Fluoxetin | N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine | Lilly-110140 | Lilly 110140 | Lilly110140 | Sarafem | Fluoxetine Hydrochloride | Prozac
Chemical Information
Molecular Formula C17H18F3NO
CAS Registry Number 54910-89-3
SMILES CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gout15.01.06.001; 14.09.01.001--Not Available
Gravitational oedema02.05.04.014; 08.01.07.005--Not Available
Guillain-Barre syndrome17.09.01.001; 11.07.01.001; 10.04.10.0050.000020%
Gynaecomastia21.05.04.003; 05.05.02.003--
Haemangioma24.03.06.004; 16.02.01.0020.000039%Not Available
Haemarthrosis15.01.01.004; 12.04.03.001; 24.07.01.0460.000020%Not Available
Haematemesis24.07.02.011; 07.12.02.0020.000089%Not Available
Haematochezia24.07.02.012; 07.12.02.003--Not Available
Haematoma24.07.01.0010.000118%
Haematuria21.10.01.018; 24.07.01.047; 20.02.01.006--
Haemoglobin13.01.05.018--Not Available
Haemolytic anaemia01.06.03.002--Not Available
Haemoptysis02.11.04.009; 24.07.01.006; 22.02.03.0040.000148%Not Available
Haemorrhage in pregnancy24.07.03.015; 18.02.01.0030.000063%Not Available
Hallucination19.10.04.0030.000404%
Hallucination, auditory19.10.04.0040.000157%Not Available
Hallucination, tactile19.10.04.0060.000059%Not Available
Hallucination, visual19.10.04.0070.000148%Not Available
Hallucinations, mixed19.10.04.0080.000030%Not Available
Hangover08.01.09.018--Not Available
Head discomfort17.02.05.0270.000030%Not Available
Headache17.14.01.0010.001539%
Hemiparesis17.01.04.0010.000089%
Hemiplegia17.01.04.0020.000128%Not Available
Henoch-Schonlein purpura24.07.06.003; 23.06.01.002; 10.02.02.004; 01.01.04.0010.000039%Not Available
Hepatic failure09.01.03.002--
Hepatic necrosis09.01.07.002--
Hepatic steatosis09.01.07.003; 14.08.04.0050.000069%Not Available
Hepatitis09.01.07.004--Not Available
Hepatitis cholestatic09.01.01.0020.000049%Not Available
The 11th Page    First    Pre   11 12 13 14 15    Next   Last    Total 35 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene